Related Experiment Video
Updated: May 7, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
Rarely metastasizing soft tissue tumours
D Chas Mangham1, Lars-Gunnar Kindblom
1Department of Musculoskeletal Pathology, Royal Orthopaedic Hospital NHS Trust, Robert Aitken Institute of Clinical Research and School of Cancer Sciences, Medical School, Birmingham University, Birmingham, UK; Department of Musculoskeletal Pathology, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Oswestry, UK.
Abstract:
Soft tissue tumours that rarely metastasize have been afforded their own subcategory in recent WHO classifications. This review discusses the nature of these tumours and the difficulty in constructing usefully simple classifications for heterogeneous and complex groups of tumours. We also highlight the specific rarely metastasizing soft tissue tumours that have been recently added to the WHO classification (phosphaturic mesenchymal tumour, pseudomyogenic haemangioendothelioma) and those entities where there have been recent important defining genetic discoveries (myxoinflammatory fibroblastic sarcoma, solitary fibrous tumour, myoepitheliomas).

